Gambacorti-Passerini C - Search Results

1

Three novel patient-derived BCR/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors.

Redaelli S, Mologni L, Rostagno R, Piazza R, Magistroni V, Ceccon M, Viltadi M, Flynn D, Gambacorti-Passerini C. Redaelli S, et al. Am J Hematol. 2012 Nov;87(11):E125-8. doi: 10.1002/ajh.23338. Epub 2012 Oct 9. Am J Hematol. 2012. PMID: 23044928 Free article.

2

In vitro transcription and translation inhibition by anti-promyelocytic leukemia (PML)/retinoic acid receptor alpha and anti-PML peptide nucleic acid.

Gambacorti-Passerini C, Mologni L, Bertazzoli C, le Coutre P, Marchesi E, Grignani F, Nielsen PE. Gambacorti-Passerini C, et al. Blood. 1996 Aug 15;88(4):1411-7. Blood. 1996. PMID: 8695861 Free article.

3

Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis.

Gambacorti-Passerini C, le Coutre P, Mologni L, Fanelli M, Bertazzoli C, Marchesi E, Di Nicola M, Biondi A, Corneo GM, Belotti D, Pogliani E, Lydon NB. Gambacorti-Passerini C, et al. Blood Cells Mol Dis. 1997 Dec;23(3):380-94. doi: 10.1006/bcmd.1997.0155. Blood Cells Mol Dis. 1997. PMID: 9446752

4

Additive antisense effects of different PNAs on the in vitro translation of the PML/RARalpha gene.

Mologni L, leCoutre P, Nielsen PE, Gambacorti-Passerini C. Mologni L, et al. Nucleic Acids Res. 1998 Apr 15;26(8):1934-8. doi: 10.1093/nar/26.8.1934. Nucleic Acids Res. 1998. PMID: 9518485 Free PMC article.

5

In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor.

le Coutre P, Mologni L, Cleris L, Marchesi E, Buchdunger E, Giardini R, Formelli F, Gambacorti-Passerini C. le Coutre P, et al. J Natl Cancer Inst. 1999 Jan 20;91(2):163-8. doi: 10.1093/jnci/91.2.163. J Natl Cancer Inst. 1999. PMID: 9923858

6

In vitro transcriptional and translational block of the bcl-2 gene operated by peptide nucleic acid.

Mologni L, Nielsen PE, Gambacorti-Passerini C. Mologni L, et al. Biochem Biophys Res Commun. 1999 Oct 22;264(2):537-43. doi: 10.1006/bbrc.1999.1548. Biochem Biophys Res Commun. 1999. PMID: 10529398

7

Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification.

le Coutre P, Tassi E, Varella-Garcia M, Barni R, Mologni L, Cabrita G, Marchesi E, Supino R, Gambacorti-Passerini C. le Coutre P, et al. Blood. 2000 Mar 1;95(5):1758-66. Blood. 2000. PMID: 10688835 Free article.

8

Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.

Mologni L, Marchesi E, Nielsen PE, Gambacorti-Passerini C. Mologni L, et al. Cancer Res. 2001 Jul 15;61(14):5468-73. Cancer Res. 2001. PMID: 11454693

9

Differences between in vivo and in vitro sensitivity to imatinib of Bcr/Abl+ cells obtained from leukemic patients.

Gambacorti-Passerini CB, Rossi F, Verga M, Ruchatz H, Gunby R, Frapolli R, Zucchetti M, Scapozza L, Bungaro S, Tornaghi L, Rossi F, Pioltelli P, Pogliani E, D'Incalci M, Corneo G. Gambacorti-Passerini CB, et al. Blood Cells Mol Dis. 2002 May-Jun;28(3):361-72. doi: 10.1006/bcmd.2002.0526. Blood Cells Mol Dis. 2002. PMID: 12367580 Clinical Trial.

10

Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias.

Gambacorti-Passerini CB, Gunby RH, Piazza R, Galietta A, Rostagno R, Scapozza L. Gambacorti-Passerini CB, et al. Lancet Oncol. 2003 Feb;4(2):75-85. doi: 10.1016/s1470-2045(03)00979-3. Lancet Oncol. 2003. PMID: 12573349 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

372 results

Search Page

Filters